SOURCE: Ramoil Management, LTD.

July 01, 2014 09:00 ET

Ramoil Management, Ltd. Announces the Establishment of RAMO Bio-Med, Inc., a Wholly Owned Subsidiary

LAS VEGAS, NV--(Marketwired - Jul 1, 2014) - RAMOIL MANAGEMENT, Ltd (OTC PINK: RAMO) (PINKSHEETS: RAMO), announces today that it has filed and established RAMO Bio-Med, Inc., a Florida wholly owned subsidiary, as the operating entity of and for the "Supercritical CO2 Molecular Extraction" technology and facilities announced in the June 30th, 2014 Press Release.

Michael Goeree, the Company's Chairman, President and Chief Executive Officer, said: "Today is a great day, when Ramoil Management, Ltd. begins to establish a clear business model, with proven technologies in a strong and growing business sector. This is but one puzzle piece in an ever evolving picture."

Mr. Goeree further states, "We can now produce our own bio-mass, oil based, extracted products and concentrates, which allows us to control quality from the raw material, through production to the finished products and thus remain consistent through product and market sales and placements. In this, we will also be afforded the opportunity to conduct extensive research of and on all forms of bio-masses."

The Company's present wholesale product lines can be reviewed at A new webpage is under development to represent the expansion and addition of our new wholly owned subsidiary RAMO Bio-Med, Inc. All vapor oil and other plant based products are expects to completed and ready for market by late August, 2014.

RAMO Bio-Med, Inc.'s initial market, since it is a Florida corporation, will be Florida, given that we are clearly eying all recent Florida developments and opportunities. To this end, the California and Nevada markets will be developed almost simultaneously with Florida or ever so slightly thereafter.

About Ramoil Management, Ltd.
Ramoil Management, Ltd. (RAMO) is a development stage company. The Company is an online wholesaler of E-cigarettes containing nutraceutical vapor oils, E-cigarette delivery systems and hydroponic lighting and nutrients.

About RAMO Bio-Med, Inc.
RAMO Bio-Med, Inc. is a wholly owned subsidiary of Ramoil Management, Ltd. (RAMO) and is a development stage company. The Company is the operating company of the newly acquired "Supercritical CO2 Molecular Extraction Technology" and will be building operating production facilities and research labs, both domestically and internationally.

Forward Looking Statements:
This news release contains forward-looking statements made by RAMOIL MANAGEMENT, LTD. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward-looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward-looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.

Contact Information


    Company and Investor Relations Contact:
    Frank Blainey, Esq. at: